Get the Stockscreener App
1.21
14.18%
-0.20
After Hours:
1.21
Vaccinex Inc Stock (VCNX) Forecast
The Vaccinex Inc (VCNX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.8224, representing a +215.90% increase from the current price of $1.21. The highest analyst price target is $4.5924, and the lowest is $3.0524.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VCNX Price Target
Average 5.3544
(+342.52% Upside)
Is Vaccinex Inc (VCNX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 26.10 | Buy |
| STOCH(9,6) | 26.77 | Neutral |
| STOCHRSI(14) | 3.9297 | Buy |
| MACD(12,26) | -0.2563 | Sell |
| ADX(14) | 23.54 | Neutral |
| William %R | -94.37 | Buy |
| CCI(14) | -287.00 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.3185
Sell
|
2.9961
Sell
|
| MA20 |
3.5863
Sell
|
3.3113
Sell
|
| MA50 |
3.2287
Sell
|
3.5283
Sell
|
| MA100 |
3.9947
Sell
|
4.0797
Sell
|
| MA200 |
5.2767
Sell
|
5.2554
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, VCNX could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on VCNX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 26.1 indicates that VCNX is oversold. This indicates that VCNX price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 26.77 indicates that VCNX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 3.9297 indicates that VCNX is oversold. This suggests that VCNX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.54 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -287 indicates that VCNX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term VCNX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Vaccinex Inc financial reports and earnings history, Vaccinex Inc (VCNX) stock could reach $5.1924 by 2030, $3.7027 by 2040 and $5.9314 by 2050. See the projected annual prices until 2050 of the Vaccinex Inc stock below:
- Vaccinex Inc (VCNX) is expected to reach an average price of $1.7461 in 2035, with a high prediction of $1.7261 and a low estimate of $1.7633. This indicates an $44.31% rise from the last recorded price of $1.21.
- Vaccinex Inc (VCNX) stock is projected to chart a bullish course in 2040, with an average price target of $3.7475, representing an $209.71% surge from its current level. The forecast ranges from a conservative $3.7111 to a sky-high $3.7027.
- Our analysts predict Vaccinex Inc (VCNX) to jump 317.00% by 2045, soaring from $4.9308 to an average price of $5.0458, potentially reaching $5.0863. While $4.9308 is the low estimate, the potential upside is significant.
- Vaccinex Inc (VCNX) stock is expected to climb by 2050, reaching an average of $5.7853, a $378.12% jump from its current level. However, a wide range of estimates exists, with high and low targets of $5.9314 and $5.8535, respectively, highlighting the market's uncertainty.
Vaccinex Inc Stock (VCNX) Year by Year Forecast
Vaccinex Inc Stock (VCNX) Price Forecast for 2025
Vaccinex Inc Stock (VCNX) is expected to reach an average price of $5.3544 in 2025, with a high prediction of $10.63 and a low estimate of $0.078. This indicates an +342.52% rise from the last recorded price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $3.306 | $3.0524 | $4.5924 | +173.22% |
| February, 2025 | $5.3308 | $3.2784 | $10.63 | +340.57% |
| March, 2025 | $3.6557 | $3.3507 | $7.3021 | +202.12% |
| April, 2025 | $2.2317 | $2.2317 | $4.0069 | +84.44% |
| May, 2025 | $2.1566 | $1.9154 | $2.5642 | +78.23% |
| June, 2025 | $2.2214 | $1.8178 | $3.0178 | +83.59% |
| July, 2025 | $1.9375 | $1.7263 | $2.4726 | +60.12% |
| August, 2025 | $2.3823 | $1.6587 | $3.4323 | +96.89% |
| September, 2025 | $4.3972 | $2.7935 | $7.8335 | +263.40% |
| October, 2025 | $3.4032 | $3.1232 | $4.8884 | +181.26% |
| November, 2025 | $0.228 | $0.078 | $5.0556 | -81.15% |
| December, 2025 | $0.1741 | $0.1005 | $0.7405 | -85.61% |
Vaccinex Inc Stock (VCNX) Price Forecast for 2026
The predicted value for Vaccinex Inc (VCNX) in 2026 is set at an average of $4.065. Estimates vary from a peak of $8.0347 to a trough of $0.0953, indicating an +235.95% surge from the present price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.5589 | $0.0953 | $1.6665 | -53.81% |
| February, 2026 | $0.4838 | $0.4338 | $0.9126 | -60.02% |
| March, 2026 | $0.8686 | $0.445 | $1.1186 | -28.21% |
| April, 2026 | $3.3547 | $0.791 | $8.0347 | +177.25% |
| May, 2026 | $2.0395 | $1.0876 | $4.2659 | +68.56% |
| June, 2026 | $1.1944 | $1.1944 | $2.0207 | -1.29% |
| July, 2026 | $0.6004 | $0.4604 | $1.2492 | -50.38% |
| August, 2026 | $1.1353 | $0.6116 | $1.7753 | -6.18% |
| September, 2026 | $1.0913 | $0.9513 | $1.4389 | -9.81% |
| October, 2026 | $0.9862 | $0.7537 | $1.1825 | -18.50% |
| November, 2026 | $0.911 | $0.6286 | $1.1074 | -24.71% |
| December, 2026 | $0.677 | $0.587 | $1.0022 | -44.05% |
Vaccinex Inc Stock (VCNX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Vaccinex Inc (VCNX) is $0.4559, with a high forecast of $0.8943 and a low forecast of $0.0175. This indicates an -62.32% decrease from the last price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.3619 | $0.3219 | $0.6883 | -70.09% |
| February, 2027 | $0.1967 | $0.1717 | $0.8943 | -83.74% |
| March, 2027 | $0.1472 | $0.0279 | $0.4179 | -87.83% |
| April, 2027 | $0.3424 | $0.356 | $0.2524 | -71.70% |
| May, 2027 | $0.1925 | $0.0175 | $0.3925 | -84.09% |
| June, 2027 | $0.3615 | $0.0427 | $0.8237 | -70.13% |
| July, 2027 | $0.1266 | $0.1078 | $0.1303 | -89.53% |
| August, 2027 | $0.1918 | $0.1554 | $0.1618 | -84.15% |
| September, 2027 | $0.1657 | $0.2094 | $0.1782 | -86.30% |
| October, 2027 | $0.3609 | $0.2621 | $0.1509 | -70.17% |
| November, 2027 | $0.2461 | $0.3897 | $0.3323 | -79.66% |
| December, 2027 | $0.32 | $0.3048 | $0.2912 | -73.55% |
Vaccinex Inc Stock (VCNX) Price Forecast for 2028
In 2028, Vaccinex Inc (VCNX) is projected to reach an average price of $0.7045, with a high projection of $0.9902 and a low estimate of $0.4188. This indicates an -41.78% fall from the last price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.6182 | $0.4188 | $0.5452 | -48.91% |
| February, 2028 | $0.9153 | $0.6925 | $0.8553 | -24.35% |
| March, 2028 | $0.8103 | $0.8463 | $0.8529 | -33.04% |
| April, 2028 | $0.955 | $0.8381 | $0.8408 | -21.07% |
| May, 2028 | $0.7134 | $0.7446 | $0.8645 | -41.04% |
| June, 2028 | $0.7951 | $0.7959 | $0.735 | -34.29% |
| July, 2028 | $0.8152 | $0.815 | $0.7673 | -32.63% |
| August, 2028 | $0.9476 | $0.8925 | $0.874 | -21.68% |
| September, 2028 | $0.9727 | $0.9664 | $0.9522 | -19.61% |
| October, 2028 | $1.0188 | $0.9704 | $0.9902 | -15.81% |
| November, 2028 | $0.9425 | $0.9644 | $0.9415 | -22.11% |
| December, 2028 | $1.0011 | $0.9507 | $0.9771 | -17.27% |
Vaccinex Inc Stock (VCNX) Price Forecast for 2029
The 2029 price forecast for Vaccinex Inc Stock (VCNX) is $4.6109 on average, with a high prediction of $8.7901 and a low estimate of $0.4316. This represents an +281.07% increase from the previous price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.0609 | $1.0084 | $1.055 | -12.32% |
| February, 2029 | $1.1292 | $1.0794 | $1.1083 | -6.68% |
| March, 2029 | $1.1574 | $1.1265 | $1.112 | -4.34% |
| April, 2029 | $0.2865 | $0.5065 | $1.0926 | -76.32% |
| May, 2029 | $0.4254 | $0.4316 | $0.3851 | -64.84% |
| June, 2029 | $0.7056 | $0.457 | $0.60 | -41.69% |
| July, 2029 | $0.6559 | $0.6944 | $0.6332 | -45.79% |
| August, 2029 | $0.6892 | $0.6595 | $0.7092 | -43.04% |
| September, 2029 | $6.2641 | $0.6411 | $8.7901 | +417.70% |
| October, 2029 | $6.5662 | $6.1562 | $8.035 | +442.66% |
| November, 2029 | $3.561 | $3.133 | $6.8074 | +194.30% |
| December, 2029 | $4.35 | $2.9411 | $5.5736 | +259.50% |
Vaccinex Inc Stock (VCNX) Price Forecast for 2030
Vaccinex Inc Stock (VCNX) is expected to reach an average price of $4.7088 in 2030, with a high forecast of $9.0317 and a low forecast of $0.3859. This signifies an +289.16% surge from the last price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.2721 | $1.9821 | $5.1924 | +87.78% |
| February, 2030 | $1.1118 | $1.0218 | $2.7893 | -8.12% |
| March, 2030 | $1.4484 | $0.6666 | $1.7191 | +19.70% |
| April, 2030 | $2.4578 | $1.3439 | $2.6287 | +103.12% |
| May, 2030 | $4.0533 | $2.066 | $4.7208 | +234.98% |
| June, 2030 | $3.0911 | $1.5584 | $4.3557 | +155.47% |
| July, 2030 | $1.3817 | $1.3326 | $3.2154 | +14.19% |
| August, 2030 | $1.9648 | $1.3399 | $2.9847 | +62.38% |
| September, 2030 | $1.7514 | $1.5699 | $2.4376 | +44.75% |
| October, 2030 | $2.3065 | $1.6768 | $9.0317 | +90.62% |
| November, 2030 | $0.7912 | $0.7912 | $4.1602 | -34.61% |
| December, 2030 | $0.6459 | $0.3859 | $1.8186 | -46.62% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):